{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:08:43Z","timestamp":1787497723966,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.juro.2018.01.069","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T08:57:10Z","timestamp":1517389030000},"page":"114-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Subcutaneous Fat Distribution is a Prognostic Biomarker for Men with Castration Resistant Prostate Cancer"],"prefix":"10.1097","volume":"200","author":[{"given":"Jong Soo","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Collaboration Unit, Yonsei University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Soo","family":"Ha","sequence":"additional","affiliation":[{"name":"Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Suk","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Urology, Shinchon Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon Ho","family":"Rha","sequence":"additional","affiliation":[{"name":"Department of Urology, Shinchon Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joon","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Urology, Shinchon Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ha","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo Chul","family":"Koo","sequence":"additional","affiliation":[{"name":"Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2018.01.069_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jjco\/hyv096","article-title":"Urologic cancers in Korea","volume":"45","author":"Koo","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.juro.2018.01.069_bib3","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.clnesp.2016.04.001","article-title":"Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel","volume":"13","author":"Cushen","year":"2016","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.juro.2018.01.069_bib4","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2018.01.069_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2018.01.069_bib6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2018.01.069_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.juro.2018.01.069_bib8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/cncr.22932","article-title":"Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer","volume":"110","author":"Halabi","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2018.01.069_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1464-410X.2011.10754.x","article-title":"Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database","volume":"110","author":"Keto","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2018.01.069_bib10","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.ejca.2015.07.042","article-title":"High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting","volume":"51","author":"Antoun","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.juro.2018.01.069_bib11","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S1470-2045(15)70033-1","article-title":"Sequencing of agents in castration-resistant prostate cancer","volume":"16","author":"Lorente","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2018.01.069_bib12","article-title":"Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2018.01.069_bib13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.juro.2018.01.069_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.juro.2018.01.069_bib15","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.juro.2018.01.069_bib16","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1200\/JCO.2010.29.8091","article-title":"Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer","volume":"28","author":"Alibhai","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2018.01.069_bib17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2018.01.069_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003088-199936020-00002","article-title":"Clinical pharmacokinetics of docetaxel","volume":"36","author":"Clarke","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.juro.2018.01.069_bib19","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1200\/JCO.2007.11.2938","article-title":"Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese","volume":"25","author":"Sparreboom","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.juro.2018.01.069_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3945\/ajcn.113.071399","article-title":"Obesity paradox in cancer: new insights provided by body composition","volume":"99","author":"Gonzalez","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.juro.2018.01.069_bib21","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s11255-014-0729-7","article-title":"Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients","volume":"46","author":"Koo","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.juro.2018.01.069_bib22","first-page":"1100","article-title":"Obesity and long-term survival after radical prostatectomy","volume":"192","author":"Chalfin","year":"2014","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2018.01.069_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MCO.0000000000000216","article-title":"Body composition phenotypes and obesity paradox","volume":"18","author":"Prado","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.juro.2018.01.069_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2018.01.069_bib25","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.juro.2013.12.047","article-title":"Sarcopenia as a predictor of complications and survival following radical cystectomy","volume":"191","author":"Smith","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.01.069_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471830106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471830106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2018.01.069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:06:26Z","timestamp":1651194386000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2018.01.069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1016\/j.juro.2018.01.069"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2018.01.069","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous Fat Distribution is a Prognostic Biomarker for Men with Castration Resistant Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2018.01.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}